| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| kras g12c inhibitor amgen | 0.35 | 0.7 | 780 | 5 | 25 |
| kras | 0.38 | 1 | 9524 | 18 | 4 |
| g12c | 1.36 | 0.7 | 5138 | 93 | 4 |
| inhibitor | 1.79 | 0.1 | 5448 | 11 | 9 |
| amgen | 0.74 | 0.8 | 1456 | 37 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| kras g12c inhibitor amgen | 0.42 | 0.9 | 1489 | 8 |
| kras g12c inhibitor 1 | 0.74 | 0.2 | 5640 | 20 |
| kras g12c on inhibitor | 0.04 | 0.2 | 6711 | 82 |
| kras g12c inhibitor drugs | 1.57 | 1 | 7645 | 94 |
| kras g12c inhibitor resistance | 0.14 | 0.7 | 5344 | 5 |
| kras g12c inhibitor-12 | 0.34 | 0.8 | 2103 | 26 |
| kras g12c inhibitor adagrasib | 1.02 | 1 | 4062 | 51 |
| fda approved kras g12c inhibitor | 0.24 | 0.3 | 7386 | 44 |
| kras g12c inhibitor fda approval | 1.83 | 0.3 | 4626 | 1 |
| amgen kras g12c fda approval | 1.09 | 0.2 | 9459 | 42 |
| the clinical kras g12c inhibitor amg 510 | 0.86 | 0.8 | 7045 | 87 |
| kras g12c inhibitor-12_1855 | 1 | 0.4 | 3365 | 83 |
| kras g12c covalent inhibitor | 1.72 | 0.1 | 9407 | 45 |
| kras g12c inhibitor clinical trial | 1.54 | 0.9 | 364 | 28 |
| roche kras g12c inhibitor | 1.72 | 0.9 | 386 | 83 |
| kras g12c inhibitor sotorasib | 0.06 | 0.5 | 1210 | 34 |
| kras g12c competitive with attgraseb drug | 1.04 | 0.3 | 7138 | 26 |
| kras g12d inhibitor clinical trial | 1.93 | 0.4 | 9131 | 48 |
| kras g12c amg 510 | 0.33 | 0.2 | 7743 | 92 |
| kras g12c mutation treatment | 1.07 | 0.5 | 7351 | 43 |
| what is kras g12c | 0.05 | 0.6 | 9518 | 74 |
| kras g12c-in-3 | 1.61 | 0.5 | 8342 | 29 |
| kras-g12 | 0.62 | 0.5 | 150 | 57 |
